Guided Therapeutics (GTHP) Revenue Growth (3y) (2013 - 2025)
Guided Therapeutics (GTHP) Revenue Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | 0.73% |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 171.44% |
| Jun 30, 2025 | 186.03% |
| Dec 31, 2024 | -74.46% |
| Dec 31, 2023 | 8.58% |
| Sep 30, 2022 | 44.22% |
| Jun 30, 2022 | 71.00% |
| Mar 31, 2022 | -34.75% |
| Dec 31, 2021 | 12.62% |
| Sep 30, 2021 | 111.79% |
| Jun 30, 2021 | -37.00% |
| Dec 31, 2020 | -38.41% |
| Sep 30, 2020 | 32.64% |
| Dec 31, 2019 | 26.68% |
| Sep 30, 2019 | -78.08% |
| Dec 31, 2018 | 67.11% |
| Sep 30, 2018 | -37.00% |
| Jun 30, 2018 | -7.17% |
| Mar 31, 2018 | -35.63% |
| Dec 31, 2017 | 101.90% |
| Sep 30, 2017 | 14.47% |